Earnings reports are critical indicators of a company's financial health and performance. Exceeding earnings expectations typically results in positive investor sentiment and an increase in share price, as it reflects better-than-anticipated company performance. Given that Organogenesis has surpassed Q1 earnings forecasts, this is likely to instill confidence among investors regarding the company's growth prospects and operational efficiency, leading to a short-term positive impact on its stock price.